Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Thonburi Healthcare Group PCL's quarterly Investments And Advances
increased
from Dec. 2025 (฿2,246 Mil) to Mar. 2026 (฿2,318 Mil) and
increased
from Mar. 2026 (฿2,318 Mil) to Jun. 2026 (฿2,344 Mil).
Thonburi Healthcare Group PCL's annual Investments And Advances
declined
from Dec. 2023 (฿2,690 Mil) to Dec. 2024 (฿2,242 Mil) but then
increased
from Dec. 2024 (฿2,242 Mil) to Dec. 2025 (฿2,246 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thonburi Healthcare Group PCL Investments And Advances Chart
What does a Investments And Advances of ฿2,344 Mil mean?
Thonburi Healthcare Group PCL (BKK:THG-R) has a Investments And Advances of ฿2,344 Mil as of Jun. 2026. Investments And Advances is all the non-current investments in affiliates, real estate, securities, etc. View historical data on Thonburi Healthcare Group PCL and its competitors.
Is Thonburi Healthcare Group PCL's Investments And Advances too high?
Thonburi Healthcare Group PCL's current Investments And Advances is ฿2,344 Mil. Overall, Thonburi Healthcare Group PCL has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Thonburi Healthcare Group PCL's Investments And Advances compare to HCA and THC?
Thonburi Healthcare Group PCL's Investments And Advances of ฿2,344 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Investments And Advances for a Healthcare Providers & Services company?
A good Investments And Advances depends on the Healthcare Providers & Services industry context. However, Investments And Advances should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Investments And Advances mean?
A high Investments And Advances can signal that a stock is expensive relative to its fundamentals. Investments And Advances is all the non-current investments in affiliates, real estate, securities, etc. View historical data on Thonburi Healthcare Group PCL and its competitors. Thonburi Healthcare Group PCL's current Investments And Advances is ฿2,344 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thonburi Healthcare Group PCL stock overvalued right now?
Based on GuruFocus' analysis, Thonburi Healthcare Group PCL (BKK:THG-R) is currently considered Fairly Valued. The stock's GF Value™ is ฿7.66, compared to a current price of ฿7.50 — trading 2.1% below its estimated fair value. The current Investments And Advances is ฿2,344 Mil. Thonburi Healthcare Group PCL's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Investments And Advances calculated?
Investments And Advances is calculated from a company's financial statements. For Thonburi Healthcare Group PCL (BKK:THG-R), the current Investments And Advances is ฿2,344 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Thonburi Healthcare Group PCL (BKK:THG-R) Overvalued in 2026?
Based on GuruFocus' analysis, Thonburi Healthcare Group PCL stock appears to be undervalued.
The current stock price of ฿7.50 is trading 2.1% below its estimated GF Value™ of ฿7.66.
GuruFocus considers Thonburi Healthcare Group PCL to be Fairly Valued.
Key valuation signals for BKK:THG-R:
Investments And Advances: ฿2,344 Mil
GF Value™: ฿7.66 vs. price of ฿7.50 (2.1% below fair value)
No single metric tells the full story. See the BKK:THG-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Thonburi Healthcare Group PCL provides medical and hospital management services. It operates private hospitals in Thailand, both in Bangkok and other parts of the country, through direct management, affiliated firms as well as joint ventures. The group's business operations involve six segments: hospital operations; hospital management; healthcare solution provider; development and sales of hospital operation software and property development and holding. It drives majority of its revenue from the hospital operations. The Group's business operations are in the same geographic area which is in Thailand and Singapore.
71GF Score
Get the complete analysis for BKK:THG-R
Investments And Advances is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:THG-R has been successfully added to your 
